Insider Transactions in Q2 2024 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 20
2024
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,997
-0.86%
|
$143,973
$9.1 P/Share
|
May 20
2024
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
9,268
-2.57%
|
$83,412
$9.1 P/Share
|
May 20
2024
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
SELL
Payment of exercise price or tax liability
|
Direct |
5,201
-3.04%
|
$46,809
$9.1 P/Share
|
May 20
2024
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,635
-2.55%
|
$77,715
$9.1 P/Share
|
May 20
2024
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,268
-2.65%
|
$83,412
$9.1 P/Share
|
May 15
2024
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,068
+0.11%
|
$18,612
$9.85 P/Share
|
May 08
2024
|
Donal O'Connor |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+14.22%
|
-
|
May 08
2024
|
Deepika Pakianathan |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+18.18%
|
-
|
May 08
2024
|
Susannah Gray |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+25.07%
|
-
|
May 08
2024
|
Dean J Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+11.57%
|
-
|
May 08
2024
|
Alsup Laurie Smaldone |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+14.07%
|
-
|
May 08
2024
|
Eran Broshy |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+11.57%
|
-
|
May 08
2024
|
Jeremy T Grant |
BUY
Grant, award, or other acquisition
|
Direct |
10,537
+32.08%
|
-
|
May 01
2024
|
Eli Samaha > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,499,124
+8.32%
|
$11,992,992
$8.75 P/Share
|
Apr 02
2024
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.8%
|
-
|
Apr 02
2024
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+13.95%
|
-
|
Apr 02
2024
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+21.71%
|
-
|
Apr 02
2024
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+17.98%
|
-
|
Apr 02
2024
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+9.7%
|
-
|